Is PORT recommended for incidentally found N2+ NSCLC after lobectomy for oligoprogressive metastatic NSCLC?

I would say it should probably be used very selectively in this population.

We routinely use PORT for stage 3 patients who have incidentally discovered N2 nodes, but I try to keep in mind that that evidence supporting its use is not strong, even in the curative setting. There's a consistent LC bene...